NCT00871416View on ClinicalTrials.gov

Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles

PHASE3CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 9, 1997

Primary Completion Date

July 18, 1997

Study Completion Date

July 18, 1997

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems

Interventions

DEVICE

NovoFine® needle 6 mm

DEVICE

NovoFine® needle 12 mm

Trial Locations (1)

8000

Novo Nordisk Investigational Site, Aarhus

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY